Cargando…

Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis: an Original Study

OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is still incurable. Although different therapies can affect the health and survival of patients. Our aim is to evaluate the effect of umbilical mesenchymal stem cells administrated intrathecally to patients with amyotrophic lateral sclerosis on disabili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barczewska, Monika, Maksymowicz, Stanisław, Zdolińska-Malinowska, Izabela, Siwek, Tomasz, Grudniak, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456414/ https://www.ncbi.nlm.nih.gov/pubmed/32725316 http://dx.doi.org/10.1007/s12015-020-10016-7

Ejemplares similares

Safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
por: Barczewska, Monika, et al.
Publicado: (2019)

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis
por: Siwek, Tomasz, et al.
Publicado: (2020)

COMPLEX TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS PATIENT
por: Białkowska, Joanna, et al.
Publicado: (2019)

Validation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale in Poland and its reliability in conditions of the medical experiment
por: Maksymowicz, Stanisław, et al.
Publicado: (2020)

The use of umbilical cord‐derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real‐life settings
por: Świątkowska‐Flis, Beata, et al.
Publicado: (2021)

Therapeutic Potential of Olfactory Ensheathing Cells and Mesenchymal Stem Cells in Spinal Cord Injuries
por: Anna, Zadroga, et al.
Publicado: (2017)

Wharton's Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study
por: Boruczkowski, Dariusz, et al.
Publicado: (2019)

Overcoming therapeutic nihilism. Breaking bad news of amyotrophic lateral sclerosis—a patient-centred perspective in rare diseases
por: Maksymowicz, Stanisław, et al.
Publicado: (2022)

Autologous Cord Blood in Children with Cerebral Palsy: A Review
por: Boruczkowski, Dariusz, et al.
Publicado: (2019)

Corrigendum to “Therapeutic Potential of Olfactory Ensheathing Cells and Mesenchymal Stem Cells in Spinal Cord Injuries”
por: Zadroga, Anna, et al.
Publicado: (2017)

Mesenchymal Stromal Cells from Different Parts of Umbilical Cord: Approach to Comparison & Characteristics
por: Semenova, Ekaterina, et al.
Publicado: (2021)

Quality of life and depression in patients with amyotrophic lateral sclerosis – does the country of origin matter?
por: Ciećwierska, Katarzyna, et al.
Publicado: (2023)

The Role of Glia in Canine Degenerative Myelopathy: Relevance to Human Amyotrophic Lateral Sclerosis
por: Golubczyk, Dominika, et al.
Publicado: (2019)

Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy
por: Zdolińska-Malinowska, Izabela, et al.
Publicado: (2022)

Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
por: Sykova, Eva, et al.
Publicado: (2021)

Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
por: Sykova, Eva, et al.
Publicado: (2021)

CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
por: Kruminis-Kaszkiel, Ewa, et al.
Publicado: (2018)

Some Spinal Cord Lesions: II. Amyotrophic Lateral Sclerosis
Publicado: (1911)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis
por: Lewis, Christina M, et al.
Publicado: (2014)

Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
por: Oh, Ki‐Wook, et al.
Publicado: (2018)

Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis
por: de Albuquerque, Milena, et al.
Publicado: (2017)

Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis
por: Chaves-Filho, Adriano Britto, et al.
Publicado: (2019)

Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients
por: Jezierska-Wozniak, Katarzyna, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Spatial Elucidation of Spinal Cord Lipid- and Metabolite- Regulations in Amyotrophic Lateral Sclerosis
por: Hanrieder, Jörg, et al.
Publicado: (2014)

Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
por: Winkler, Ethan A., et al.
Publicado: (2012)

A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis
por: Marini, Cecilia, et al.
Publicado: (2016)

Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis
por: Marini, Cecilia, et al.
Publicado: (2018)

Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
por: Ban, Jelena, et al.
Publicado: (2019)

Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts—Novel Techniques
por: El Mendili, Mohamed Mounir, et al.
Publicado: (2019)

T1 hyperintensity in the spinal cord: A diagnostic marker of amyotrophic lateral sclerosis?
por: Pai, Vivek, et al.
Publicado: (2022)

Cervical spinal cord atrophy in amyotrophic lateral sclerosis across disease stages
por: Nigri, Anna, et al.
Publicado: (2023)

Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
por: Gugliandolo, Agnese, et al.
Publicado: (2019)

Multi-Parametric Spinal Cord MRI as Potential Progression Marker in Amyotrophic Lateral Sclerosis
por: El Mendili, Mohamed-Mounir, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bc9fe0j56d2m9pj69clfqt12tt